1. Risk evaluation and mitigation strategies: modifications and revisions Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2020 Subject(s): Drug ApprovalDrug IndustryDrug LabelingRisk Evaluation and MitigationUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Policy for certain REMS requirements during the COVID-19 public health emergency: guidance for industry and health care professionals Publication: Silver Spring, MD : Center for Drug Evaluation and Research, March 2020 Subject(s): Coronavirus Infections -- epidemiologyPandemicsRisk Evaluation and MitigationUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
